staff

Mary De May, MD, is the Hellman Master Clinician and Hellman Family Distinguished Professor of Neurology at the UCSF Edward and Pearl Fein Memory and Aging Center. A compassionate and dedicated physician, Dr. De May has been part of the Fein Memory and Aging Center since 2000, providing exceptional clinical care and professional mentorship in the field of neurodegenerative diseases.

As the Assistant Director for Programs and Strategy, Stacey oversees education and training at the Global Brain Health Institute (GBHI) including recruitment and selection, curriculum, and monitoring and evaluation of the Atlantic Fellows Program. She oversees the administration of the Equity in Brain Health Certificate Program at UCSF as well as operational areas of international event management and communications.

Kamalini Ranasinghe, MBBS, PhD, is an assistant professor at the UCSF Edward and Pearl Fein Memory and Aging Center within the Weill Institute for Neurosciences. She specializes in investigating the network dysfunction underlying neurodegenerative diseases, including Alzheimer’s disease and frontotemporal lobar degeneration.

Julio C. Rojas, MD, PhD, is a neurologist at the UCSF Edward and Pearl Fein Memory and Aging Center, specializing in the diagnosis and treatment of dementia.

Gil Rabinovici, MD, is a professor in the UCSF Department of Neurology and holds the Edward and Pearl Fein Distinguished Professorship in Memory and Aging. He is a behavioral neurologist at the UCSF Edward and Pearl Fein Memory and Aging Center (Fein MAC), where he cares for individuals with cognitive disorders. Dr. Rabinovici earned his bachelor’s degree from Stanford University and his medical degree from Northwestern University Feinberg School of Medicine.

Eleanor O'Brien coordinates the educational programs at the Memory and Aging Center.

David Perry, MD, is a neurologist and associate professor of neurology at the UCSF Edward and Pearl Fein Memory and Aging Center, part of the UCSF Weill Institute for Neurosciences. He specializes in the care of patients with neurodegenerative diseases, including Alzheimer’s disease, frontotemporal dementia, and other conditions that cause cognitive impairment. Dr.

Alissa joined the Seeley Selective Vulnerability Research Laboratory in 2011 as a postdoctoral fellow. Her background is in neurodegeneration research. Alissa completed a BSc degree with honors in biomedical science in 2004 and a PhD degree in anatomy in 2009 from the University of Auckland, New Zealand, where she investigated the variable pattern of cortical neuronal loss in Huntington’s disease. In the Seeley lab, she is investigating the selective vulnerability of von Economo neurons (VENs) in frontotemporal dementia.

Albert joined the Memory and Aging Center in 2007, initially serving as the center’s Data Manager. For four years he acted as the liaison between clinical research personnel and programmers on the technology team, helping identify and systematize improvements in data collection design and implementation across research projects. Since then he’s transitioned wholly to the technology team, serving as one of the main programmers for LAVA, the open-source clinical research data management solution used at the MAC and at sites around the world.